Download PDF
Thromb Haemost 2008; 99(05): 968-969
DOI: 10.1160/TH08-02-0123
Letters to the Editor
Schattauer GmbH

Aspirin response variability assessed with the PFA-100 device

Jean-Luc Reny
1   Department of Internal Medicine, Béziers Hospital, Béziers, France
2   EA 2992, Montpellier 1 University, Nîmes, France
,
Isabelle Quéré
2   EA 2992, Montpellier 1 University, Nîmes, France
,
Philippe de Moerloose
3   Division of Angiology and Haemostasis, Department of Internal Medicine, Faculty of Medicine and University Hospitals of Geneva, Geneva, Switzerland
,
Pierre Fontana
3   Division of Angiology and Haemostasis, Department of Internal Medicine, Faculty of Medicine and University Hospitals of Geneva, Geneva, Switzerland
› Author Affiliations
Further Information

Publication History

Received 28 February 2008

Accepted 12 March 2008

Publication Date:
30 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Crescente M, Di Castelnuovo A, Iacoviello L. et al. Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review. Thromb Haemost 2008; 99: 14-26.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Hovens MM, Snoep JD, Eikenboom JC. et al. Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review. Am Heart J 2007; 153: 175-181.
    CrossrefPubMedGoogle Scholar
  • 3 Krasopoulos G, Brister SJ, Beattie WS. et al. Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis. Br Med J 2008; 26 (336) 195-198.
    PubMedGoogle Scholar
  • 4 Fontana P, Reny JL. Laboratory-defined aspirin resistance and recurrent cardiovascular events. Arch Intern Med 2008; 168: 549-550.
    CrossrefPubMedGoogle Scholar
  • 5 Reny JL, De Moerloose P, Dauzat M. et al. Use of the PFA-100™ closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis. J Thromb Haemost 2008; 6: 444-450.
    CrossrefPubMedGoogle Scholar